Re: Separation AgreementInformation and Invention Assignment Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • California
This letter sets forth the substance of the separation agreement (the “Agreement”) that Angion Biomedica Corp. (the “Company”) is offering to you pursuant to the terms of your employment agreement with the Company dated May 1, 2018 (the “2018 Agreement”).
FIRST AMENDMENT TO CONFIDENTIAL CONSULTING AGREEMENTConfidential Consulting Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations
This first amendment (the “First Amendment”) to the Confidential Consulting Agreement dated June 3, 2020 (the “Agreement”) by and between the parties hereto, is executed as of the date shown on the signature page (the “Effective Date”), by and between FLG Partners, LLC, a California limited liability company (“FLG”), and Angion Biomedica Corp. (“Client”).
FIRST AMENDMENT AGREEMENT (hereinafter referred to as the “Amendment Agreement”) BetweenFirst Amendment Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations
WHEREAS, pursuant to section 13, each Party may not share other Party’s confidential information to any Third Party without the prior written consent of the Disclosing Party, knowing that the Third Party definition is very broad and then includes also vendors which will be used by each Party in the performance of its obligations;
SUPPLY AGREEMENTSupply Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
THIS SUPPLY AGREEMENT (this “Agreement”) is made and entered into as of the date of last signature (the “Effective Date”) by and between Angion Biomedica Corp, a company organized under the laws of USA located at 51 Charles Lindbergh Blvd, Uniondale, NY 11553 (“ANGION”) and Solara Active Pharma Sciences Ltd., a company organized under the laws of India located at Batra Centre, No.28, Sardar Patel Road, Guindy, Chennai - 600 032, Tamilnadu, India (“SOLARA”).
THIRD AMENDMENT TO CONFIDENTIAL CONSULTING AGREEMENTConfidential Consulting Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations
This third amendment (the “Third Amendment”) to the Confidential Consulting Agreement dated June 3, 2020 (the “Agreement”) by and between the parties hereto, is executed as of the date shown on the signature page (the “Effective Date”), by and between FLG Partners, LLC, a California limited liability company (“FLG”), and Angion Biomedica Corporation (“Client”). Capitalized terms used herein without definition shall have the meanings ascribed to them in the Agreement
SECOND AMENDMENT TO CONFIDENTIAL CONSULTING AGREEMENTConfidential Consulting Agreement • March 30th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations
This second amendment (the “Second Amendment”) to the Confidential Consulting Agreement dated June 3, 2020 (the “Agreement”) by and between the parties hereto, is executed as of the date shown on the signature page (the “Effective Date”), by and between FLG Partners, LLC, a California limited liability company (“FLG”), and Angion Biomedica Corp. (“Client”).
